Financial Results for the quarter and year ended March 31, 2026. Further please note the below mentioned details of borrowing as system was not allowing us to take decimal: 1. Outstanding ....
Awaiting price reaction for this filing.
Garodia Chemicals Ltd reported a net profit of Rs 391.67 lakhs for FY26 compared to a net loss of Rs 20.77 lakhs in FY25. The profit is primarily from other income of Rs 405.88 lakhs, which relates to loan settlements from related parties (Mr. Mahesh Garodia, Mr. Nishant Garodia, and Garodia Sons Private Limited) under a Base Resolution Plan (BRP) approved by NCLT. The company underwent significant capital restructuring: share capital was reduced from 72 lakh shares (Rs 10 each) to 2.63 lakh shares (Rs 1 each), with accumulated losses of Rs 7.17 crores partially written off, followed by allotment of 50 lakh new shares to a new promoter. Borrowings reduced significantly from Rs 481.87 lakhs to Rs 31.74 lakhs. Total assets declined from Rs 13.95 lakhs to Rs 9.39 lakhs.
The stock saw a major turnaround from loss to profit due to one-time BRP settlement income, not core business performance. The capital restructuring and deleveraging indicate the company is emerging from financial distress, but the small asset base and negligible operating revenue raise concerns about business continuity.